Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING - Net Sales and Segment Profit (Details)

v3.23.3
SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Segment net sales $ 3,820 $ 2,867 $ 12,779 $ 12,008
Segment loss 1,942 1,299 6,902 6,373
Non-cash share-based compensation     (954) (2,606)
Depreciation and amortization (290) (305) (750) (950)
Goodwill impairment (19,000) (19,000)
Loss from operations (3,377) (24,324) (10,682) (39,392)
Loss on debt extinguishment, net 0 0 0 2,263
Gain on remeasurement of warrant liability (60) (196) (5) (2,009)
Gain on investment 0 0 0 (6,851)
Impairment investment 3,705 0 3,705 0
Foreign exchange loss 275 669 297 1,144
Interest and amortization of debt issuance cost 5 (58) 23 2,696
Other (income) expense, net (31) 102 (19) 111
Loss before income taxes and equity investment loss (7,271) (24,841) (14,683) (36,746)
Operating Segments        
Segment Reporting Information [Line Items]        
Segment net sales 3,820 2,867 12,779 12,008
Segment loss (1,909) (2,637) (4,643) (10,035)
Operating Segments | Cannabinoid        
Segment Reporting Information [Line Items]        
Segment net sales 1,442 613 4,537 3,166
Segment loss (2,225) (2,732) (6,237) (11,144)
Operating Segments | Non-Cannabinoid        
Segment Reporting Information [Line Items]        
Segment net sales 2,378 2,254 8,242 8,842
Segment loss 316 95 1,594 1,109
Other        
Segment Reporting Information [Line Items]        
Unallocated corporate expenses (1,706) (1,424) (5,835) (6,801)
Non-cash share-based compensation (52) (958) (954) (2,606)
Depreciation and amortization 290 (305) 750 (950)
Goodwill impairment 0 (19,000) 0 (19,000)
Loss from operations $ (3,377) $ (24,324) $ (10,682) $ (39,392)